We explored mechanistic signatures of different lesion types in the brain of patients with progressive MS: normal-appearing white matter (NAWM), active, chronic active (slowly expanding), inactive and repairing (remyelinating) lesions compared to control brain white matter areas. By comprehensive tissue-transcriptomics and bioinformatics of about 100 brain areas from these different MS lesion types, we have also established a unique public, interactive molecular database of the activated genes: the MS Atlas (Fig. 1).

Fig. 1. Establishing molecular signature of brain lesion types in progressive multiple sclerosis. After classifying and microdissecting different lesion types from the MS brain, we performed a comprehensive transcriptome analysis by RNA sequencing, and created the MS-Atlas. Through an unbiased de novo enriched protein-protein network analysis we found that TGFBR2 was a major hub of significantly expressed genes that were shared by the different lesion types. Created by Biorender.com.

Our unbiased search across subsets of multiple lesions provided a discovery of specific molecular signatures validated by different approaches.  Among others, we found that the cytokine receptor TGFbR2 was the central molecule in de novo molecular networks of common differentially expressed genes (FDR<0.05) in all the different MS lesion types (Fig. 1). We also found that chronic active, slowly expanding lesion had the most unique signature and the highest number of unique significantly expressed genes (n=2213), with approximately 70% related to axonal/neuronal functions (Fig. 2).

Moreover, we used the transcriptome data to create an online database, the MS-Atlas for international MS research. This interactive user-friendly online web-service (www.msatlas.dk) aids also research in other neurological diseases, as it allows researchers and clinicians to (i) search for certain molecules of interest, (ii) compare gene panels from functional cell/animal studies, and (iii) discover mechanistic markers using de novo network enrichment in different lesion types (Fig. 1).

Fig. 2. The uniqueness of cjronic active, slowly expanding lesions in the MS brain. By comparing all the significantly regulated genes across the different lesion types, chronic active lesion had the highest number of unique genes. Chronic active lesions were also highly enriched in neuron/axon-specific biological processes indicated by predefined cellular components. Created by Biorender.com.

In conclusion, we established molecular signature of different lesion types in the brain of progressive MS, and this may help in understanding molecular processes behind chronic, ongoing tissue injury versus repair. Our MS atlas is a valuable resource to fuel future MS research, and a new basis for treatment development.

Maria L. Elkjaer, Zsolt Illes
Department of Neurology, Odense University Hospital, University of Southern Denmark, Odense, Denmark

Publication

Molecular signature of different lesion types in the brain white matter of patients with progressive multiple sclerosis
Elkjaer ML, Frisch T, Reynolds R, Kacprowski T, Burton M, Kruse TA, Thomassen M, Baumbach J, Illes Z.
Acta Neuropathol Commun. 2019 Dec 11

Read offline:     

Related Articles:

	Is multiple sclerosis triggered by immunological… Multiple sclerosis (MS) is an autoimmune disease where immune cells (T cells) and antibodies progressively damage the myelin sheath surrounding nerve cells leading to their loss of function. We have…
	Defects in mismatch repair increase cancer risk and… Microsatellites are formed by 1-6 nucleotide base pairs that are repeated in direct order 5-50 times. Repetitive DNA including microsatellites are mainly present in non-coding DNA regions that occupy more…
	Sleep abnormalities in different clinical stages of… Sleep abnormalities are commonly observed in individuals with schizophrenia and related psychotic disorders. Research shows that over half of people with these conditions have trouble sleeping. Poor sleep also often…
	Deep Molecular Profiling to understand the biology… Alzheimer disease (AD) is a complex, polygenic disease with genetic, cellular, pathologic, and clinical heterogeneity. Advances in high-throughput sequencing and omics technologies have accelerated the drive toward personalized medicine. Human…
	Systemic therapy in juvenile localized scleroderma Juvenile localized scleroderma, also known as morphea, is an rare condition, it occurs around 1 in 5000 children, where the skin and the tissues underneath the skin like fat tissue,…
	Molecular classification of glioma stem cells Comprehensive genetic analysis of glioblastomas by The Cancer Genome Atlas (TCGA) has proposed a new classification based on genetic abnormalities. The characteristic genetic abnormalities identified in the TCGA are promising…